Literature DB >> 21396383

Overlapping neurobiology of learned helplessness and conditioned defeat: implications for PTSD and mood disorders.

Sayamwong E Hammack1, Matthew A Cooper, Kimberly R Lezak.   

Abstract

Exposure to traumatic events can increase the risk for major depressive disorder (MDD) as well as posttraumatic stress disorder (PTSD), and pharmacological treatments for these disorders often involve the modulation of serotonergic (5-HT) systems. Several behavioral paradigms in rodents produce changes in behavior that resemble symptoms of MDD and these behavioral changes are sensitive to antidepressant treatments. Here we review two animal models in which MDD-like behavioral changes are elicited by exposure to an acute traumatic event during adulthood, learned helplessness (LH) and conditioned defeat. In LH, exposure of rats to inescapable, but not escapable, tailshock produces a constellation of behavioral changes that include deficits in fight/flight responding and enhanced anxiety-like behavior. In conditioned defeat, exposure of Syrian hamsters to a social defeat by a more aggressive animal leads to a loss of territorial aggression and an increase in submissive and defensive behaviors in subsequent encounters with non-aggressive conspecifics. Investigations into the neural substrates that control LH and conditioned defeat revealed that increased 5-HT activity in the dorsal raphe nucleus (DRN) is critical for both models. Other key brain regions that regulate the acquisition and/or expression of behavior in these two paradigms include the basolateral amygdala (BLA), central nucleus of the amygdala (CeA) and bed nucleus of the stria terminalis (BNST). In this review, we compare and contrast the role of each of these neural structures in mediating LH and conditioned defeat, and discuss the relevance of these data in developing a better understanding of the mechanisms underlying trauma-related depression. This article is part of a Special Issue entitled 'Post-Traumatic Stress Disorder'.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21396383      PMCID: PMC3433056          DOI: 10.1016/j.neuropharm.2011.02.024

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  138 in total

Review 1.  Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer.

Authors:  David L Walker; Michael Davis
Journal:  Brain Struct Funct       Date:  2008-06-05       Impact factor: 3.270

2.  Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior.

Authors:  Sayamwong E Hammack; Joseph Cheung; Kimberly M Rhodes; Kristin C Schutz; William A Falls; Karen M Braas; Victor May
Journal:  Psychoneuroendocrinology       Date:  2009-01-31       Impact factor: 4.905

3.  Social defeat stress activates medial amygdala cells that express type 2 corticotropin-releasing factor receptor mRNA.

Authors:  E M Fekete; Y Zhao; C Li; V Sabino; W W Vale; E P Zorrilla
Journal:  Neuroscience       Date:  2009-04-07       Impact factor: 3.590

4.  Activation of 5-HT1A autoreceptors in the dorsal raphe nucleus reduces the behavioral consequences of social defeat.

Authors:  Matthew A Cooper; Kathleen E McIntyre; Kim L Huhman
Journal:  Psychoneuroendocrinology       Date:  2008-08-09       Impact factor: 4.905

5.  Effects of BNST lesions in female rats on forced swimming and navigational learning.

Authors:  Pinar Pezuk; Elif Aydin; Ayla Aksoy; Resit Canbeyli
Journal:  Brain Res       Date:  2008-06-27       Impact factor: 3.252

6.  Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons.

Authors:  Lynn G Kirby; Emily Freeman-Daniels; Julia C Lemos; John D Nunan; Christophe Lamy; Adaure Akanwa; Sheryl G Beck
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

7.  Aggressive encounters alter the activation of serotonergic neurons and the expression of 5-HT1A mRNA in the hamster dorsal raphe nucleus.

Authors:  M A Cooper; M S Grober; C R Nicholas; K L Huhman
Journal:  Neuroscience       Date:  2009-04-09       Impact factor: 3.590

8.  Exercise is associated with reduction in the anxiogenic effect of mCPP on acoustic startle.

Authors:  James H Fox; Sayamwong E Hammack; William A Falls
Journal:  Behav Neurosci       Date:  2008-08       Impact factor: 1.912

9.  Role of the bed nucleus of the stria terminalis in the acquisition and expression of conditioned defeat in Syrian hamsters.

Authors:  Chris M Markham; Alisa Norvelle; Kim L Huhman
Journal:  Behav Brain Res       Date:  2008-10-19       Impact factor: 3.332

10.  Corticotropin-releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity.

Authors:  Gina L Forster; Ronald B Pringle; Nicholas J Mouw; Shawn M Vuong; Michael J Watt; Andrew R Burke; Christopher A Lowry; Cliff H Summers; Kenneth J Renner
Journal:  Eur J Neurosci       Date:  2008-07       Impact factor: 3.698

View more
  50 in total

1.  Chronic social subordination stress modulates glutamic acid decarboxylase (GAD) 67 mRNA expression in central stress circuits.

Authors:  Ryan Makinson; Kerstin H Lundgren; Kim B Seroogy; James P Herman
Journal:  Physiol Behav       Date:  2015-07-01

2.  Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior.

Authors:  Rebecca A Brachman; Josephine C McGowan; Jennifer N Perusini; Sean C Lim; Thu Ha Pham; Charlene Faye; Alain M Gardier; Indira Mendez-David; Denis J David; René Hen; Christine A Denny
Journal:  Biol Psychiatry       Date:  2015-05-04       Impact factor: 13.382

Review 3.  Pituitary adenylate cyclase activating polypeptide in stress-related disorders: data convergence from animal and human studies.

Authors:  Sayamwong E Hammack; Victor May
Journal:  Biol Psychiatry       Date:  2014-12-09       Impact factor: 13.382

4.  Coordinate regulation of noradrenergic and serotonergic brain regions by amygdalar neurons.

Authors:  T A Retson; E J Van Bockstaele
Journal:  J Chem Neuroanat       Date:  2013-05-04       Impact factor: 3.052

5.  Pituitary adenylate cyclase-activating polypeptide (PACAP) in the bed nucleus of the stria terminalis (BNST) increases corticosterone in male and female rats.

Authors:  K R Lezak; E Roelke; O M Harris; I Choi; S Edwards; N Gick; G Cocchiaro; G Missig; C W Roman; K M Braas; D J Toufexis; V May; S E Hammack
Journal:  Psychoneuroendocrinology       Date:  2014-03-25       Impact factor: 4.905

6.  A pilot study to investigate the induction and manipulation of learned helplessness in healthy adults.

Authors:  Joseph J Taylor; Daniel J Neitzke; George Khouri; Jeffrey J Borckardt; Ron Acierno; Peter W Tuerk; Matthew Schmidt; Mark S George
Journal:  Psychiatry Res       Date:  2014-06-16       Impact factor: 3.222

7.  Breaking bonds in male prairie vole: long-term effects on emotional and social behavior, physiology, and neurochemistry.

Authors:  P Sun; A S Smith; K Lei; Y Liu; Z Wang
Journal:  Behav Brain Res       Date:  2014-02-20       Impact factor: 3.332

Review 8.  Pituitary Adenylate Cyclase-Activating Peptide (PACAP) Signaling and the Dark Side of Addiction.

Authors:  Olivia W Miles; Victor May; Sayamwong E Hammack
Journal:  J Mol Neurosci       Date:  2018-08-03       Impact factor: 3.444

9.  Inhibition of vasopressin V1a receptors in the medioventral bed nucleus of the stria terminalis has sex- and context-specific anxiogenic effects.

Authors:  Natalia Duque-Wilckens; Michael Q Steinman; Sarah A Laredo; Rebecca Hao; Allison M Perkeybile; Karen L Bales; Brian C Trainor
Journal:  Neuropharmacology       Date:  2016-07-21       Impact factor: 5.250

10.  Naloxone-reversible modulation of pain circuitry by left prefrontal rTMS.

Authors:  Joseph J Taylor; Jeffrey J Borckardt; Melanie Canterberry; Xingbao Li; Colleen A Hanlon; Truman R Brown; Mark S George
Journal:  Neuropsychopharmacology       Date:  2013-01-11       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.